Answers are grounded in this paper and cite their sources.
Observational study reveals manageable tuberculosis incidence predominantly in acute myeloid leukemia, highlighting that standard anti-tuberculosis therapy allows chemotherapy continuation.
We studied 130 consecutive cases of acute leukemia over a 2-year period and identified 9 cases (6.9%) with active tuberculosis (TB). Eight patients with TB had acute myeloid leukemia (AML). Patients with AML were more likely to develop TB as compared to patients with acute lymphoblastic leukemia (ALL) despite the wider use of steroids and radiotherapy in ALL protocols {OR 4.41 (CI 0.53-36.44)}. Only 1 patient died of disseminated TB during post induction neutropenia. All other patients were successfully managed using current anti-tuberculous therapy (ATT). On the whole, TB did not cause any undue delay in chemotherapy and did not flare up during subsequent chemotherapy cycles. However it is not a commonly described infection in acute leukemia and a high index of suspicion is warranted especially in areas endemic for TB.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: